Norman Fields Gottscho Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Hold
1,480
0.54% 25
2026
Q1
$1.36M Hold
1,480
0.45% 29
2025
Q4
$1.59M Hold
1,480
0.51% 26
2025
Q3
$1.13M Hold
1,480
0.36% 31
2025
Q2
$1.15M Hold
1,480
0.38% 31
2025
Q1
$1.22M Hold
1,480
0.41% 27
2024
Q4
$1.14M Buy
1,480
+20
+1% +$16.6K 0.38% 27
2024
Q3
$1.29M Hold
1,460
0.43% 29
2024
Q2
$1.37M Hold
1,460
0.48% 25
2024
Q1
$1.14M Hold
1,460
0.42% 31
2023
Q4
$851K Hold
1,460
0.34% 35
2023
Q3
$784K Hold
1,460
0.34% 39
2023
Q2
$685K Hold
1,460
0.29% 41
2023
Q1
$501K Hold
1,460
0.22% 48
2022
Q4
$534K Hold
1,460
0.25% 48
2022
Q3
$472K Hold
1,460
0.23% 46
2022
Q2
$473K Hold
1,460
0.22% 51
2022
Q1
$418K Hold
1,460
0.16% 58
2021
Q4
$403K Hold
1,460
0.15% 59
2021
Q3
$337K Hold
1,460
0.13% 62
2021
Q2
$335K Hold
1,460
0.13% 62
2021
Q1
$273K Hold
1,460
0.12% 65
2020
Q4
$247K Hold
1,460
0.11% 58
2020
Q3
$216K Hold
1,460
0.11% 59
2020
Q2
$240K Hold
1,460
0.13% 59
2020
Q1
$203K Buy
+1,460
New +$201K 0.13% 59
2019
Q1
Sell
-1,920
Closed -$222K 76
2018
Q4
$222K Hold
1,920
0.13% 66
2018
Q3
$206K Buy
+1,920
New +$192K 0.1% 73

Other funds holding LLY

Norman Fields Gottscho Capital Management's LLY Position: Q2 2026 in Review

Norman Fields Gottscho Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,480 shares worth $1.78M. The position accounts for 0.54% of the portfolio, ranked #25.

Norman Fields Gottscho Capital Management first reported a position in LLY in Q3 2018 and has held it in 28 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Norman Fields Gottscho Capital Management held 1,480 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • Norman Fields Gottscho Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.54% of Norman Fields Gottscho Capital Management's portfolio in Q2 2026, its #25 holding.
  • Norman Fields Gottscho Capital Management first reported a position in Eli Lilly in Q3 2018 and has held it in 28 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.